Differential effects of genes of the Rb1 signalling pathway on osteosarcoma incidence and latency in alpha-particle irradiated mice.

作者: Iria Gonzalez-Vasconcellos , Tanja Domke , Virginija Kuosaite , Irene Esposito , Bahar Sanli-Bonazzi

DOI: 10.1007/S00411-010-0339-4

关键词:

摘要: Osteosarcoma is the most frequent secondary malignancy following radiotherapy of patients with bilateral retinoblastoma. This suggests that Rb1 tumour suppressor gene might confer genetic susceptibility towards radiation-induced osteosarcoma. To define contribution pathway in multistep process radiation carcinogenesis, we evaluated somatic allelic changes affecting itself as well its upstream regulator p16 murine osteosarcoma induced by 227Th incorporation. distinguish between germline predisposition and effect a 2-hit loss, two mouse models harbouring heterozygote defects were tested for incidence latency irradiation. We could show all tumours arising BALB/c × CBA/CA hybrid mice (wild-type p16) carried loss either (76.5%) or (59%). In none tumours, found concordant retention heterozygosity at both loci. Heterozygote knock-out exhibit significant increase incorporation (22/24 Rb1+/− vs. 2/18 Rb1+/+, p = 4 10−5), without latency. contrast, had no change incidence, but pronounced reduction (LT50% 355 days p16+/− 445 p16+/+, 8 10−3). These data suggest influence early steps osteosarcomagenesis, whereas alterations mainly affect later stages promotion growth.

参考文章(33)
William F. Dietrich, Joyce C. Miller, Robert G. Steen, Mark Merchant, Deborah Damron, Robert Nahf, Alec Gross, Diane C. Joyce, Michael Wessel, Robert D. Dredge, Andre Marquis, Lincoln D. Stein, Nathan Goodman, David C. Page, Eric S. Lander, A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nature Genetics. ,vol. 7, pp. 220- 245 ,(1994) , 10.1038/NG0694SUPP-220
Theodora Stavrou, Christina M. Bromley, H. Stacy Nicholson, Julianne Byrne, Roger J. Packer, Alisa M. Goldstein, Gregory H. Reaman, Prognostic factors and secondary malignancies in childhood medulloblastoma. Journal of Pediatric Hematology Oncology. ,vol. 23, pp. 431- 436 ,(2001) , 10.1097/00043426-200110000-00008
R. E. Rowland, A. F. Stehney, H. F. Lucas, Dose-Response Relationships for Female Radium Dial Workers Radiation Research. ,vol. 76, pp. 368- 383 ,(1978) , 10.2307/3574786
Adrian Merlo, James G. Herman, Li Mao, Daniel J. Lee, Edward Gabrielson, Peter C. Burger, Stephen B. Baylin, David Sidransky, 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine. ,vol. 1, pp. 686- 692 ,(1995) , 10.1038/NM0795-686
C Giacinti, A Giordano, RB and cell cycle progression Oncogene. ,vol. 25, pp. 5220- 5227 ,(2006) , 10.1038/SJ.ONC.1209615
R. Day, B. Johnson, M. Skolnick, A Kamb, N. Gruis, J Weaver-Feldhaus, Q Liu, K Harshman, S. Tavtigian, E Stockert, A cell cycle regulator potentially involved in genesis of many tumor types Science. ,vol. 264, pp. 436- 440 ,(1994) , 10.1126/SCIENCE.8153634
Andrew G. Huvos, Helen Q. Woodard, Postradiation sarcomas of bone. Health Physics. ,vol. 55, pp. 631- 636 ,(1988) , 10.1097/00004032-198810000-00004
Mark Harland, Elizabeth A. Holland, Paola Ghiorzo, Michela Mantelli, Giovanna Bianchi-Scarr�, Alisa M. Goldstein, Margaret A. Tucker, Bruce A.J. Ponder, Graham J. Mann, D. Timothy Bishop, Julia Newton Bishop, Mutation screening of the CDKN2A promoter in melanoma families. Genes, Chromosomes and Cancer. ,vol. 28, pp. 45- 57 ,(2000) , 10.1002/(SICI)1098-2264(200005)28:1<45::AID-GCC6>3.0.CO;2-F
Jiri Lukas, David Parry, Louise Aagaard, David J. Mann, Jirina Bartkova, Michael Strauss, Gordon Peters, Jiri Bartek, Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature. ,vol. 375, pp. 503- 506 ,(1995) , 10.1038/375503A0